An observational study in Oncology, sponsored by Ain Shams University. Status unknown at 1 site in Egypt. Open to female participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2018-12-27.
Sponsored by Ain Shams University · Observational
A prospective cohort study to assess RHEA ( recurrent vaginal bleeding, hypertension, endometrial thickness and age) scoring model for prediction of endometrial carcinoma
All postmenopausal women (who had their menses stopped for at least one year above age of 40) with vaginal bleeding.
Exclusion Criteria:
Other: Scoring model
Determining risk factors an calculating the risk score, recurrent vaginal bleeding 3, hypertension 2, age and endometrial thickness 1 for each
Specificity and sensitivity of RHEA scoring mdel
Positive and negative productive values, specificity and sensitivity of RHEA scoring model
Time frame: One year
Variables to increase specificity and sensitivity of the score model
Obesity, diabetes mellitus and family history
Time frame: One year
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ain Shams University